Zhejiang E-P Equipment
603194
Harbin Jiuzhou Group
300040
Shenglan Technology
300843
Fullink Technology
301067
Shenzhen Tongye Technology
300960
CN Stock MarketDetailed Quotes
002393 Tianjin Lisheng Pharmaceutical
- 17.42
- +0.09+0.52%
Noon Break Dec 24 11:30 CST
4.49BMarket Cap23.86P/E (TTM)
17.46High17.16Low24.18KlotVolume17.18Open17.33Pre Close41.95MTurnover0.95%Turnover Ratio12.42P/E (Static)257.94MShares19.4452wk High0.90P/B4.45BFloat Cap12.1952wk Low19.06Limit Up255.44MShs Float41.85Historical High15.60Limit Down1.73%Amplitude10.83Historical Low0.43Dividend TTM17.35Avg Price10.52KlotAsk2.46%Div YieldTTM100Lot Size13.15KlotBid
Tianjin Lisheng Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 12.31%1.02B | 13.25%744.64M | 8.71%364.85M | 0.56%1.15B | 1.06%911.57M | 6.95%657.49M | 9.51%335.6M | 5.00%1.15B | 7.94%902.02M | 4.67%614.74M |
| Operating revenue | 12.31%1.02B | 13.25%744.64M | 8.71%364.85M | 0.56%1.15B | 1.06%911.57M | 6.95%657.49M | 9.51%335.6M | 5.00%1.15B | 7.94%902.02M | 4.67%614.74M |
| Other operating revenue | ---- | 76.95%3.55M | ---- | 27.25%7.7M | ---- | -23.81%2.01M | ---- | 29.70%6.05M | ---- | -53.14%2.64M |
| Total operating cost | 18.71%903.12M | 11.77%630.23M | 7.78%309.28M | -3.00%969.53M | -1.25%760.76M | 5.88%563.85M | 10.39%286.96M | 3.83%999.48M | 5.23%770.42M | 1.67%532.52M |
| Operating cost | 29.98%458.5M | 30.83%326.45M | 30.87%172.14M | -3.73%468.15M | -3.67%352.76M | 2.57%249.52M | 6.70%131.53M | 7.00%486.28M | 4.75%366.19M | -0.74%243.27M |
| Operating tax surcharges | 3.10%17.8M | 6.84%12.82M | 11.24%6.06M | -5.13%22.87M | -2.80%17.27M | -2.51%12M | -13.95%5.45M | 7.44%24.11M | 6.24%17.76M | 10.38%12.31M |
| Operating expense | 4.25%284.79M | 6.79%212.3M | -4.68%96.43M | -5.08%318.94M | -1.83%273.17M | 6.73%198.8M | 16.28%101.17M | -7.41%336.02M | 5.39%278.27M | 1.68%186.26M |
| Administration expense | 15.12%88.83M | 9.82%61.1M | 1.23%27.54M | -0.74%113.61M | -2.87%77.16M | 10.36%55.63M | 19.27%27.2M | 8.17%114.46M | 0.57%79.44M | -1.56%50.41M |
| Financial expense | -9.31%-40.66M | -109.13%-37.12M | -653.75%-17.48M | 11.43%-59.66M | 38.22%-37.2M | 26.90%-17.75M | 55.40%-2.32M | 22.68%-67.36M | -7.14%-60.21M | 6.93%-24.28M |
| -Interest expense (Financial expense) | 244.75%1.69M | 360.09%1.72M | 616.85%922.02K | -14.78%745.83K | -16.04%490.57K | -14.68%374.92K | 79.63%128.62K | 173.07%875.18K | 115.77%584.32K | 220.04%439.45K |
| -Interest Income (Financial expense) | -14.75%-43.35M | -114.07%-38.99M | -632.56%-18.41M | 11.32%-60.53M | 37.93%-37.78M | 26.57%-18.22M | 52.81%-2.51M | 22.09%-68.25M | -7.55%-60.86M | 5.77%-24.81M |
| Research and development | 20.96%93.86M | -16.70%54.69M | 2.74%24.58M | -0.33%105.62M | -12.77%77.6M | 1.70%65.65M | -6.99%23.93M | 1.82%105.98M | 12.65%88.97M | 9.00%64.55M |
| Credit Impairment Loss | -111.35%-34.68K | -121.43%-34.68K | -67.70%25.07K | 216.03%2.62M | 1,282.87%305.48K | 726.66%161.84K | --77.59K | -7,149.54%-2.26M | -183.17%-25.83K | -156.89%-25.83K |
| Asset Impairment Loss | ---228.11K | ---- | ---- | -48.97%-29.25M | ---- | ---- | ---- | -30.06%-19.63M | ---2.31M | ---- |
| Other net revenue | -68.07%80.75M | -43.83%6.35M | 40.77%9.1M | 913.65%236.31M | 3,325.14%252.91M | 76.21%11.3M | 53.58%6.47M | -483.04%-29.04M | -54.03%7.38M | -44.68%6.41M |
| Fair value change income | --1.31M | --1.12M | ---- | 122.02%621.77K | ---- | ---- | ---- | --280.06K | ---- | ---- |
| Invest income | 535.44%76.81M | -71.43%3.02M | 32.69%8.2M | -34.54%15.5M | 49.54%12.09M | 85.18%10.56M | 51.68%6.18M | 23.04%23.68M | -29.64%8.08M | -26.77%5.7M |
| -Including: Investment income associates | 711.03%70.23M | ---- | 81.51%6.48M | 6.19%11.02M | 23.10%8.66M | 49.07%7.34M | -12.39%3.57M | -20.85%10.38M | -9.67%7.03M | -36.78%4.92M |
| Asset deal income | --0 | ---- | ---- | 785.53%238.7M | --238.61M | --14.74K | --14.74K | ---34.82M | ---- | ---- |
| Other revenue | 52.01%2.9M | 300.07%2.24M | 357.53%873.27K | 118.82%8.11M | 16.61%1.91M | -23.68%560.61K | 42.59%190.87K | 9.05%3.71M | -57.37%1.64M | -75.98%734.57K |
| Operating profit | -50.11%201.41M | 15.07%120.75M | 17.35%64.67M | 255.57%419.81M | 190.49%403.73M | 18.40%104.94M | 8.63%55.11M | -13.76%118.06M | 16.20%138.98M | 17.91%88.63M |
| Add:Non operating Income | 22.25%1.65M | -62.42%449.97K | -88.51%129.91K | 59.40%560.9K | 192.71%1.35M | 163.15%1.2M | 1,775.89%1.13M | -43.21%351.88K | 42.89%461.94K | 106.49%455.04K |
| Less:Non operating expense | 865.55%1.03M | 453.51%562.79K | 931.90%17.06K | 193.06%152.26K | 5,082.02%106.94K | 4,826.96%101.68K | 1,553.63%1.65K | -87.25%51.95K | -99.34%2.06K | -99.04%2.06K |
| Total profit | -50.11%202.03M | 13.78%120.64M | 15.20%64.78M | 255.02%420.21M | 190.43%404.97M | 19.03%106.03M | 10.73%56.24M | -13.68%118.36M | 16.57%139.44M | 18.51%89.08M |
| Less:Income tax cost | -45.92%33.69M | 22.13%19.36M | -8.51%8.91M | 135.83%58.39M | 132.33%62.31M | -7.46%15.85M | 10.21%9.74M | 64.89%24.76M | 22.44%26.82M | 23.06%17.13M |
| Net profit | -50.88%168.33M | 12.31%101.28M | 20.16%55.88M | 286.54%361.83M | 204.26%342.67M | 25.33%90.18M | 10.84%46.5M | -23.34%93.61M | 15.26%112.62M | 17.47%71.95M |
| Net profit from continuing operation | -50.88%168.33M | 12.31%101.28M | 20.16%55.88M | 286.54%361.83M | 204.26%342.67M | 25.33%90.18M | 10.84%46.5M | -23.34%93.61M | 15.26%112.62M | 17.47%71.95M |
| Less:Minority Profit | ---917.97K | ---1.07M | ---3.28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net profit of parent company owners | -50.61%169.25M | 13.50%102.35M | 27.22%59.16M | 286.54%361.83M | 204.26%342.67M | 25.33%90.18M | 10.84%46.5M | -23.34%93.61M | 15.26%112.62M | 17.47%71.95M |
| Earning per share | ||||||||||
| Basic earning per share | -50.38%0.66 | 14.29%0.4 | 28.00%0.32 | 286.27%1.97 | 114.52%1.33 | -10.26%0.35 | 8.70%0.25 | -23.88%0.51 | 14.81%0.62 | 14.71%0.39 |
| Diluted earning per share | -50.38%0.66 | 14.29%0.4 | 28.00%0.32 | 286.27%1.97 | 114.52%1.33 | -10.26%0.35 | 8.70%0.25 | -23.88%0.51 | 14.81%0.62 | 14.71%0.39 |
| Other composite income | 329.93%238.67M | -1,847.70%-103.8M | ||||||||
| Other composite income of parent company owners | ---- | ---- | ---- | 329.93%238.67M | ---- | ---- | ---- | -1,847.70%-103.8M | ---- | ---- |
| Total composite income | -50.88%168.33M | 12.31%101.28M | 20.16%55.88M | 5,992.10%600.49M | 204.26%342.67M | 25.33%90.18M | 10.84%46.5M | -107.96%-10.19M | 15.26%112.62M | 17.47%71.95M |
| Total composite income of parent company owners | -50.88%168.33M | 13.50%102.35M | 27.22%59.16M | 5,992.10%600.49M | 204.26%342.67M | 25.33%90.18M | 10.84%46.5M | -107.96%-10.19M | 15.26%112.62M | 17.47%71.95M |
| Total composite income of minority owners | ---- | ---1.07M | ---3.28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
